Dianthus Therapeutics DNTH Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's operating lease liabilities (total)?
- Dianthus Therapeutics (DNTH) reported operating lease liabilities (total) of $1.36M in Q1 2026.
- How has Dianthus Therapeutics's operating lease liabilities (total) changed year-over-year?
- Dianthus Therapeutics's operating lease liabilities (total) decreased by 2.3% year-over-year, from $1.4M to $1.36M.
- What is the long-term trend for Dianthus Therapeutics's operating lease liabilities (total)?
- Over 2 years (2022 to 2024), Dianthus Therapeutics's operating lease liabilities (total) has grown at a -77.7% compound annual growth rate (CAGR), from $29.96M to $1.49M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.